Eterna Therapeutics
ERNA
7 hedge funds and large institutions have $4.47M invested in Eterna Therapeutics in 2015 Q2 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 7 → 7 (0)
41% less capital invested
Capital invested by funds: $7.63M → $4.47M (-$3.16M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIC
AWM Investment Company
New York
|
+$259K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$6K |
ERNA Hedge Fund Activity: Q2 2015 in Review
7 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Eterna Therapeutics (ERNA) for Q2 2015, worth a combined $4.47M — down 41% from $7.63M a quarter earlier.
Fund positioning in ERNA was balanced in Q2 2015: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was AWM Investment Company, adding an estimated $259K. The largest seller was Susquehanna International Group, cutting an estimated $6K.
- 7 institutional investors held Eterna Therapeutics (ERNA) as of Q2 2015, unchanged from Q1 2015.
- Funds reported $4.47M of Eterna Therapeutics stock for Q2 2015, down 41% quarter-over-quarter.
- 0 funds opened new Eterna Therapeutics positions in Q2 2015 and 0 closed out.
- The largest Eterna Therapeutics buyer in Q2 2015 was AWM Investment Company, an estimated $259K added.
- The largest Eterna Therapeutics seller in Q2 2015 was Susquehanna International Group, an estimated $6K sold.
Based on aggregated 13F filings for Q2 2015.